Astria Therapeutics
ATXS
ATXS
51 hedge funds and large institutions have $51M invested in Astria Therapeutics in 2020 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 15 increasing their positions, 16 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.25% less ownership
Funds ownership: 7.45% → 7.2% (-0.25%)
1% less capital invested
Capital invested by funds: $51.5M → $51M (-$489K)
6% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 16
Holders
51
Holding in Top 10
1
Calls
$1.17M
Puts
$644K
Top Buyers
| 1 | +$2.29M | |
| 2 | +$860K | |
| 3 | +$592K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$418K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$323K |
Top Sellers
| 1 | -$1.29M | |
| 2 | -$883K | |
| 3 | -$669K | |
| 4 |
Two Sigma Investments
New York
|
-$280K |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$225K |